## 2-(4-Fluoro-3-(trifluoromethyl)phenoxy)-N-(phenylmethyl)butanamide: A Look at its Importance in Research
**2-(4-Fluoro-3-(trifluoromethyl)phenoxy)-N-(phenylmethyl)butanamide** is a complex organic compound with a long and descriptive chemical name. It's important to understand that this is not a common household chemical, and it's likely being studied in specific research contexts.
Without further context, it's impossible to definitively say why this specific compound is significant in research. However, we can glean some information from its structure and potential properties:
* **Structure:** The name itself provides clues about the molecule's structure. It contains:
* **A phenyl ring:** This is a common aromatic ring structure found in many pharmaceuticals.
* **A butanamide group:** This indicates the presence of an amide functional group attached to a four-carbon chain.
* **Fluorine and trifluoromethyl groups:** These are known to affect a molecule's properties, such as its lipophilicity (how well it interacts with fats), its stability, and its reactivity.
* **Potential Properties:** Given its structure, the compound likely has several interesting properties, potentially making it useful in various areas of research:
* **Pharmaceutical Research:** The presence of a phenyl ring and an amide group suggests it could be a potential drug candidate, potentially acting as an inhibitor of enzymes, receptors, or other biological targets.
* **Material Science Research:** The fluorine and trifluoromethyl groups could contribute to its potential use as a component in advanced materials like polymers or coatings due to their impact on properties like thermal stability and water repellency.
**To truly understand its importance, we need more context.** For example:
* **What is the research area of interest?** This could be drug discovery, materials science, or another area entirely.
* **What are the specific properties being studied?** Are researchers interested in its biological activity, its chemical reactivity, its physical properties, or something else?
* **What are the potential applications of the compound?** This could be anything from a new drug for a specific disease to a component in a novel polymer material.
In conclusion, **2-(4-Fluoro-3-(trifluoromethyl)phenoxy)-N-(phenylmethyl)butanamide** is a complex organic compound with a potential for applications in research, particularly in the fields of pharmaceuticals and materials science. Its specific importance depends on the research context and its observed properties.
2-(4-fluoro-3-(trifluoromethyl)phenoxy)-N-(phenylmethyl)butanamide: inhibits phytoene-desaturase; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
beflubutamid : A racemate comprising equimolar amounts of (R)- and (S)-beflubutamid. An inhibitor of carotenoid biosynthesis, it is used for the pre- and early post-emergence control of broad-leaved weeds in a variety of cereal crops. The (-)-enantiomer has at least 1000 times higher herbicidal activity than the (+)-enantiomer. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
N-benzyl-2-[4-fluoro-3-(trifluoromethyl)phenoxy]butanamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 2-[4-fluoro-3-(trifluoromethyl)phenoxy]butyric acid with the amino group of benzylamine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
ID Source | ID |
---|---|
PubMed CID | 6451159 |
CHEBI ID | 138203 |
SCHEMBL ID | 115747 |
MeSH ID | M0593611 |
Synonym |
---|
beflubutamid |
CHEBI:138203 |
n-benzyl-2-[4-fluoro-3-(trifluoromethyl)phenoxy]butanamide |
n-benzyl-2-[4-fluoro-3-(trifluoromethyl)phenoxy]butyramide |
beflubutamid [iso] |
(rs)-n-benzyl-2-(alpha,alpha,alpha,4-tetrafluoro-m-tolyloxy)butyramide |
113614-08-7 |
unii-yw9853iq3u |
yw9853iq3u , |
2-[4-fluoro-3-(trifluoromethyl)phenoxy]-n-(phenylmethyl)butanamide |
SCHEMBL115747 |
DTXSID7057941 |
n-benzyl-2-(4-fluoro-3-trifluoromethylphenoxy)butanoic amide |
2-(4-fluoro-3-(trifluoromethyl)phenoxy)-n-(phenylmethyl)butanamide |
butanamide, 2-(4-fluoro-3-(trifluoromethyl)phenoxy)-n-(phenylmethyl)- |
beflubutamid, (+/-)- |
benfluamid |
ubh-820 |
ubh 820 |
beflubutamid, pestanal(r), analytical standard |
Z3301415053 |
beflubutamid 100 microg/ml in acetonitrile |
n-benzyl-2-(4-fluoro-3-(trifluoromethyl)phenoxy)butanamide |
Q22712766 |
c18h17f4no2 |
butanamide, 2-[4-fluoro-3-(trifluoromethyl)phenoxy]-n-(phenylmethyl)- |
AKOS040744438 |
Excerpt | Relevance | Reference |
---|---|---|
"In field experiments, assessment of herbicide selectivity and efficacy rarely takes advantage of dose-response regressions." | ( Assessing herbicide symptoms by using a logarithmic field sprayer. Andreasen, C; Cunha, BRD; Nielsen, J; Rasmussen, J; Ritz, C; Streibig, JC, 2019) | 0.51 |
"Suitable nonlinear regression models are now available for fitting dose-response data from a logarithmic sprayer in field experiments." | ( Assessing herbicide symptoms by using a logarithmic field sprayer. Andreasen, C; Cunha, BRD; Nielsen, J; Rasmussen, J; Ritz, C; Streibig, JC, 2019) | 0.51 |
Class | Description |
---|---|
monocarboxylic acid amide | A carboxamide derived from a monocarboxylic acid. |
aromatic ether | Any ether in which the oxygen is attached to at least one aryl substituent. |
monofluorobenzenes | Any member of the class of fluorobenzenes containing a mono- or poly-substituted benzene ring carrying a single fluorine substitutent. |
(trifluoromethyl)benzenes | An organofluorine compound that is (trifluoromethyl)benzene and derivatives arising from substitution of one or more of the phenyl hydrogens. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.18) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |